Search results
Results from the WOW.Com Content Network
The Beers Criteria for Potentially Inappropriate Medication Use in Older Adults, commonly called the Beers List, [1] are guidelines published by the American Geriatrics Society (AGS) for healthcare professionals to help improve the safety of prescribing medications for adults 65 years and older in all except palliative settings.
Mark Howard Beers (April 24, 1954 – February 28, 2009) [1] was an American geriatrician whose research on drug interactions among the elderly led to the creation of the eponymous Beers criteria, which lists prescription medications that may have deleterious side effects in older patients.
The people taking the GLP-1 drugs also had increased GI-related issues, low blood pressure, and arthritis, as well as certain kidney conditions and pancreatitis—most of which are already known ...
The most common side effects of these drugs that led to withdrawals were mental disturbances, cardiac side effects, and drug abuse or drug dependence. Deaths were associated with seven products. [84] Ephedra was removed from the US market in 2004 over concerns that it raises blood pressure and could lead to strokes and death. [85]
GLP-1 drugs used for weight loss involve all kinds of side effects—good and not-so-good—that may or may not strike the average user. (Reminder that there are many of these meds now.
These medications mimic a protein in your body called glucagon-like peptide 1 (or GLP-1), explains Mir Ali, M.D., a bariatric surgeon and medical director of MemorialCare Surgical Weight Loss ...
Kidney function gradually decreases as someone ages. The elderly are also likely to be underweight. In addition, these older people tend to be dehydrated and be taking other medications. These factors increase the likelihood of developing side effects of digoxin and digoxin toxicity. Often lowering the dose is considered by the prescriber. [6]
GLP-1 drugs for weight loss and type 2 diabetes include dulaglutide, liraglutide, and semaglutide. ... A 2022 study sponsored by Eli Lilly followed more than 2,500 adults with a BMI of 30 or more ...